Iovance Biotherapeutics I...

NASDAQ: IOVA · Real-Time Price · USD
2.54
0.09 (3.67%)
At close: Aug 15, 2025, 3:59 PM
2.58
1.38%
After-hours: Aug 15, 2025, 06:54 PM EDT

Iovance Biotherapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-5.76 -4.31 -2.57 -8.56
PEG Ratio
0.18 0.18 -0.22 -0.46
PS Ratio
13.07 1.61K n/a n/a
PB Ratio
3.02 3.27 2.04 4.71
P/FCF Ratio
-5.89 -4.98 -3.25 -11.03
P/OCF Ratio
-6.08 -5.28 -3.48 -12.85
OCF/S Ratio
-2.15 -304.31 n/a n/a
Debt / Equity Ratio
0.08 0.13 0.17 0.12
Quick Ratio
3.31 2.70 5.24 5.69
Current Ratio
3.74 2.79 5.24 5.69
Asset Turnover
0.18 0.00 n/a n/a
Interest Coverage
n/a n/a -133.63 n/a
Return on Equity
-0.52 -0.76 -0.79 -0.55
Return on Assets
-0.41 -0.57 -0.6 -0.44
Return on Invested Capital
-0.48 -0.67 -0.95 -0.49
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.24 -8.05 n/a n/a
Net Profit Margin
-2.27 -373.45 n/a n/a
Pretax Profit Margin
-2.29 -376.38 n/a n/a
Operating Profit Margin
-2.41 -387.35 n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-2.14 -359.49 n/a n/a